HEADER TRANSFERASE 14-FEB-19 6NZP TITLE CRYSTAL STRUCTURE OF TYROSINE KINASE 2 JH2 (PSEUDO KINASE DOMAIN) TITLE 2 COMPLEXED WITH COMPOUND-11 AKA 6-CYCLOPROPANEAMIDO-4-{[2-METHOXY-3- TITLE 3 (1-METHYL-1H-1,2,4-TRI AZOL-3-YL)PHENYL]AMINO}-N-(?H?) TITLE 4 METHYLPYRIDAZINE-3-CARBOXAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NON-RECEPTOR TYROSINE-PROTEIN KINASE TYK2; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PSEUDO KINASE DOMAIN, RESIDUES 575-869; COMPND 5 EC: 2.7.10.2; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TYK2; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS JTK1, PSEUDO KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.A.KHAN REVDAT 3 11-OCT-23 6NZP 1 REMARK REVDAT 2 06-NOV-19 6NZP 1 JRNL REVDAT 1 31-JUL-19 6NZP 0 JRNL AUTH S.T.WROBLESKI,R.MOSLIN,S.LIN,Y.ZHANG,S.SPERGEL,J.KEMPSON, JRNL AUTH 2 J.S.TOKARSKI,J.STRNAD,A.ZUPA-FERNANDEZ,L.CHENG,D.SHUSTER, JRNL AUTH 3 K.GILLOOLY,X.YANG,E.HEIMRICH,K.W.MCINTYRE,C.CHAUDHRY,J.KHAN, JRNL AUTH 4 M.RUZANOV,J.TREDUP,D.MULLIGAN,D.XIE,H.SUN,C.HUANG, JRNL AUTH 5 C.D'ARIENZO,N.ARANIBAR,M.CHINEY,A.CHIMALAKONDA,W.J.PITTS, JRNL AUTH 6 L.LOMBARDO,P.H.CARTER,J.R.BURKE,D.S.WEINSTEIN JRNL TITL HIGHLY SELECTIVE INHIBITION OF TYROSINE KINASE 2 (TYK2) FOR JRNL TITL 2 THE TREATMENT OF AUTOIMMUNE DISEASES: DISCOVERY OF THE JRNL TITL 3 ALLOSTERIC INHIBITOR BMS-986165. JRNL REF J.MED.CHEM. V. 62 8973 2019 JRNL REFN ISSN 0022-2623 JRNL PMID 31318208 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00444 REMARK 2 REMARK 2 RESOLUTION. 2.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.04 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 60.9 REMARK 3 NUMBER OF REFLECTIONS : 16711 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.191 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.238 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.690 REMARK 3 FREE R VALUE TEST SET COUNT : 783 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 39 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.35 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 7.91 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 429 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2336 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 410 REMARK 3 BIN R VALUE (WORKING SET) : 0.2319 REMARK 3 BIN FREE R VALUE : 0.2675 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.43 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4019 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 63 REMARK 3 SOLVENT ATOMS : 76 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.65 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.74 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.18850 REMARK 3 B22 (A**2) : -0.58360 REMARK 3 B33 (A**2) : -1.60490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.84980 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.330 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 1.687 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.320 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.933 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.902 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4233 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5791 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1427 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 764 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4233 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 530 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 4911 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.14 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.98 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.10 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6NZP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-FEB-19. REMARK 100 THE DEPOSITION ID IS D_1000239743. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-OCT-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : STARANISO REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16712 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 48.040 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.6 REMARK 200 DATA REDUNDANCY : 3.400 REMARK 200 R MERGE (I) : 0.09300 REMARK 200 R SYM (I) : 0.06000 REMARK 200 FOR THE DATA SET : 9.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.61 REMARK 200 COMPLETENESS FOR SHELL (%) : 62.4 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.86500 REMARK 200 R SYM FOR SHELL (I) : 0.00000 REMARK 200 FOR SHELL : 1.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4WOV REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.20 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200 MM AMMONIUM SULFATE, AND 100 MM REMARK 280 CACODYLATE BUFFER, PH 7.5, 30%(W/V) PEG 5000 (METHYL ETHER), REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.48500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 553 REMARK 465 GLY A 554 REMARK 465 SER A 555 REMARK 465 SER A 556 REMARK 465 HIS A 557 REMARK 465 HIS A 558 REMARK 465 HIS A 559 REMARK 465 HIS A 560 REMARK 465 HIS A 561 REMARK 465 HIS A 562 REMARK 465 SER A 563 REMARK 465 SER A 564 REMARK 465 GLY A 565 REMARK 465 GLU A 566 REMARK 465 THR A 567 REMARK 465 VAL A 568 REMARK 465 ARG A 569 REMARK 465 PHE A 570 REMARK 465 GLN A 571 REMARK 465 GLY A 572 REMARK 465 HIS A 573 REMARK 465 MET A 574 REMARK 465 ASN A 575 REMARK 465 LEU A 576 REMARK 465 SER A 577 REMARK 465 GLN A 578 REMARK 465 LEU A 579 REMARK 465 VAL A 610 REMARK 465 GLU A 611 REMARK 465 GLY A 612 REMARK 465 SER A 613 REMARK 465 GLY A 614 REMARK 465 ASP A 615 REMARK 465 PRO A 616 REMARK 465 GLU A 617 REMARK 465 GLU A 618 REMARK 465 GLY A 619 REMARK 465 LYS A 620 REMARK 465 MET A 621 REMARK 465 ASP A 622 REMARK 465 ASP A 623 REMARK 465 GLU A 624 REMARK 465 ASP A 625 REMARK 465 PRO A 626 REMARK 465 LEU A 627 REMARK 465 VAL A 628 REMARK 465 PRO A 629 REMARK 465 GLY A 630 REMARK 465 ARG A 631 REMARK 465 ASP A 632 REMARK 465 ARG A 633 REMARK 465 GLY A 634 REMARK 465 GLN A 635 REMARK 465 GLY A 787 REMARK 465 ALA A 788 REMARK 465 ASN A 789 REMARK 465 SER A 790 REMARK 465 LEU A 791 REMARK 465 MET B 553 REMARK 465 GLY B 554 REMARK 465 SER B 555 REMARK 465 SER B 556 REMARK 465 HIS B 557 REMARK 465 HIS B 558 REMARK 465 HIS B 559 REMARK 465 HIS B 560 REMARK 465 HIS B 561 REMARK 465 HIS B 562 REMARK 465 SER B 563 REMARK 465 SER B 564 REMARK 465 GLY B 565 REMARK 465 GLU B 566 REMARK 465 THR B 567 REMARK 465 VAL B 568 REMARK 465 ARG B 569 REMARK 465 PHE B 570 REMARK 465 GLN B 571 REMARK 465 GLY B 572 REMARK 465 HIS B 573 REMARK 465 MET B 574 REMARK 465 ASN B 575 REMARK 465 LEU B 576 REMARK 465 SER B 577 REMARK 465 GLN B 578 REMARK 465 LEU B 579 REMARK 465 GLU B 611 REMARK 465 GLY B 612 REMARK 465 SER B 613 REMARK 465 GLY B 614 REMARK 465 ASP B 615 REMARK 465 PRO B 616 REMARK 465 GLU B 617 REMARK 465 GLU B 618 REMARK 465 GLY B 619 REMARK 465 LYS B 620 REMARK 465 MET B 621 REMARK 465 ASP B 622 REMARK 465 ASP B 623 REMARK 465 GLU B 624 REMARK 465 ASP B 625 REMARK 465 PRO B 626 REMARK 465 LEU B 627 REMARK 465 VAL B 628 REMARK 465 PRO B 629 REMARK 465 GLY B 630 REMARK 465 ARG B 631 REMARK 465 ASP B 632 REMARK 465 ARG B 633 REMARK 465 GLY B 634 REMARK 465 GLY B 786 REMARK 465 GLY B 787 REMARK 465 ALA B 788 REMARK 465 ASN B 789 REMARK 465 SER B 790 REMARK 465 LEU B 869 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 587 CG CD CE NZ REMARK 470 ARG A 609 CG CD NE CZ NH1 NH2 REMARK 470 GLN A 664 CD OE1 NE2 REMARK 470 ARG A 679 NE CZ NH1 NH2 REMARK 470 GLU A 682 CG CD OE1 OE2 REMARK 470 ARG A 701 NE CZ NH1 NH2 REMARK 470 GLU A 770 CD OE1 OE2 REMARK 470 GLU A 812 CD OE1 OE2 REMARK 470 GLN A 816 CG CD OE1 NE2 REMARK 470 GLN A 855 CG CD OE1 NE2 REMARK 470 ARG A 868 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 869 CG CD1 CD2 REMARK 470 LYS B 587 CG CD CE NZ REMARK 470 ARG B 609 CG CD NE CZ NH1 NH2 REMARK 470 VAL B 610 CG1 CG2 REMARK 470 GLN B 635 CG CD OE1 NE2 REMARK 470 GLN B 664 CG CD OE1 NE2 REMARK 470 ARG B 703 NE CZ NH1 NH2 REMARK 470 GLU B 749 CG CD OE1 OE2 REMARK 470 GLU B 770 CD OE1 OE2 REMARK 470 GLU B 774 OE1 OE2 REMARK 470 LEU B 791 CG CD1 CD2 REMARK 470 GLU B 822 CD OE1 OE2 REMARK 470 ARG B 860 NE CZ NH1 NH2 REMARK 470 ARG B 868 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 592 -128.93 -124.38 REMARK 500 GLU A 691 -65.45 -24.19 REMARK 500 ASN A 734 53.15 -152.88 REMARK 500 LEU A 815 -13.26 82.58 REMARK 500 LEU A 849 49.78 -98.21 REMARK 500 ARG A 868 -18.78 -141.65 REMARK 500 LEU B 592 -149.21 -117.19 REMARK 500 ASN B 734 53.23 -153.23 REMARK 500 ALA B 748 143.87 166.52 REMARK 500 LEU B 815 -11.08 87.46 REMARK 500 LEU B 849 49.50 -97.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LB7 A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LB7 B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CL B 902 DBREF 6NZP A 575 869 UNP P29597 TYK2_HUMAN 575 869 DBREF 6NZP B 575 869 UNP P29597 TYK2_HUMAN 575 869 SEQADV 6NZP MET A 553 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY A 554 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER A 555 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER A 556 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 557 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 558 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 559 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 560 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 561 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 562 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER A 563 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER A 564 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY A 565 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLU A 566 UNP P29597 EXPRESSION TAG SEQADV 6NZP THR A 567 UNP P29597 EXPRESSION TAG SEQADV 6NZP VAL A 568 UNP P29597 EXPRESSION TAG SEQADV 6NZP ARG A 569 UNP P29597 EXPRESSION TAG SEQADV 6NZP PHE A 570 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLN A 571 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY A 572 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS A 573 UNP P29597 EXPRESSION TAG SEQADV 6NZP MET A 574 UNP P29597 EXPRESSION TAG SEQADV 6NZP MET B 553 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY B 554 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER B 555 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER B 556 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 557 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 558 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 559 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 560 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 561 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 562 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER B 563 UNP P29597 EXPRESSION TAG SEQADV 6NZP SER B 564 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY B 565 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLU B 566 UNP P29597 EXPRESSION TAG SEQADV 6NZP THR B 567 UNP P29597 EXPRESSION TAG SEQADV 6NZP VAL B 568 UNP P29597 EXPRESSION TAG SEQADV 6NZP ARG B 569 UNP P29597 EXPRESSION TAG SEQADV 6NZP PHE B 570 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLN B 571 UNP P29597 EXPRESSION TAG SEQADV 6NZP GLY B 572 UNP P29597 EXPRESSION TAG SEQADV 6NZP HIS B 573 UNP P29597 EXPRESSION TAG SEQADV 6NZP MET B 574 UNP P29597 EXPRESSION TAG SEQRES 1 A 317 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 317 GLU THR VAL ARG PHE GLN GLY HIS MET ASN LEU SER GLN SEQRES 3 A 317 LEU SER PHE HIS ARG VAL ASP GLN LYS GLU ILE THR GLN SEQRES 4 A 317 LEU SER HIS LEU GLY GLN GLY THR ARG THR ASN VAL TYR SEQRES 5 A 317 GLU GLY ARG LEU ARG VAL GLU GLY SER GLY ASP PRO GLU SEQRES 6 A 317 GLU GLY LYS MET ASP ASP GLU ASP PRO LEU VAL PRO GLY SEQRES 7 A 317 ARG ASP ARG GLY GLN GLU LEU ARG VAL VAL LEU LYS VAL SEQRES 8 A 317 LEU ASP PRO SER HIS HIS ASP ILE ALA LEU ALA PHE TYR SEQRES 9 A 317 GLU THR ALA SER LEU MET SER GLN VAL SER HIS THR HIS SEQRES 10 A 317 LEU ALA PHE VAL HIS GLY VAL CYS VAL ARG GLY PRO GLU SEQRES 11 A 317 ASN ILE MET VAL THR GLU TYR VAL GLU HIS GLY PRO LEU SEQRES 12 A 317 ASP VAL TRP LEU ARG ARG GLU ARG GLY HIS VAL PRO MET SEQRES 13 A 317 ALA TRP LYS MET VAL VAL ALA GLN GLN LEU ALA SER ALA SEQRES 14 A 317 LEU SER TYR LEU GLU ASN LYS ASN LEU VAL HIS GLY ASN SEQRES 15 A 317 VAL CYS GLY ARG ASN ILE LEU LEU ALA ARG LEU GLY LEU SEQRES 16 A 317 ALA GLU GLY THR SER PRO PHE ILE LYS LEU SER ASP PRO SEQRES 17 A 317 GLY VAL GLY LEU GLY ALA LEU SER ARG GLU GLU ARG VAL SEQRES 18 A 317 GLU ARG ILE PRO TRP LEU ALA PRO GLU CYS LEU PRO GLY SEQRES 19 A 317 GLY ALA ASN SER LEU SER THR ALA MET ASP LYS TRP GLY SEQRES 20 A 317 PHE GLY ALA THR LEU LEU GLU ILE CYS PHE ASP GLY GLU SEQRES 21 A 317 ALA PRO LEU GLN SER ARG SER PRO SER GLU LYS GLU HIS SEQRES 22 A 317 PHE TYR GLN ARG GLN HIS ARG LEU PRO GLU PRO SER CYS SEQRES 23 A 317 PRO GLN LEU ALA THR LEU THR SER GLN CYS LEU THR TYR SEQRES 24 A 317 GLU PRO THR GLN ARG PRO SER PHE ARG THR ILE LEU ARG SEQRES 25 A 317 ASP LEU THR ARG LEU SEQRES 1 B 317 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 317 GLU THR VAL ARG PHE GLN GLY HIS MET ASN LEU SER GLN SEQRES 3 B 317 LEU SER PHE HIS ARG VAL ASP GLN LYS GLU ILE THR GLN SEQRES 4 B 317 LEU SER HIS LEU GLY GLN GLY THR ARG THR ASN VAL TYR SEQRES 5 B 317 GLU GLY ARG LEU ARG VAL GLU GLY SER GLY ASP PRO GLU SEQRES 6 B 317 GLU GLY LYS MET ASP ASP GLU ASP PRO LEU VAL PRO GLY SEQRES 7 B 317 ARG ASP ARG GLY GLN GLU LEU ARG VAL VAL LEU LYS VAL SEQRES 8 B 317 LEU ASP PRO SER HIS HIS ASP ILE ALA LEU ALA PHE TYR SEQRES 9 B 317 GLU THR ALA SER LEU MET SER GLN VAL SER HIS THR HIS SEQRES 10 B 317 LEU ALA PHE VAL HIS GLY VAL CYS VAL ARG GLY PRO GLU SEQRES 11 B 317 ASN ILE MET VAL THR GLU TYR VAL GLU HIS GLY PRO LEU SEQRES 12 B 317 ASP VAL TRP LEU ARG ARG GLU ARG GLY HIS VAL PRO MET SEQRES 13 B 317 ALA TRP LYS MET VAL VAL ALA GLN GLN LEU ALA SER ALA SEQRES 14 B 317 LEU SER TYR LEU GLU ASN LYS ASN LEU VAL HIS GLY ASN SEQRES 15 B 317 VAL CYS GLY ARG ASN ILE LEU LEU ALA ARG LEU GLY LEU SEQRES 16 B 317 ALA GLU GLY THR SER PRO PHE ILE LYS LEU SER ASP PRO SEQRES 17 B 317 GLY VAL GLY LEU GLY ALA LEU SER ARG GLU GLU ARG VAL SEQRES 18 B 317 GLU ARG ILE PRO TRP LEU ALA PRO GLU CYS LEU PRO GLY SEQRES 19 B 317 GLY ALA ASN SER LEU SER THR ALA MET ASP LYS TRP GLY SEQRES 20 B 317 PHE GLY ALA THR LEU LEU GLU ILE CYS PHE ASP GLY GLU SEQRES 21 B 317 ALA PRO LEU GLN SER ARG SER PRO SER GLU LYS GLU HIS SEQRES 22 B 317 PHE TYR GLN ARG GLN HIS ARG LEU PRO GLU PRO SER CYS SEQRES 23 B 317 PRO GLN LEU ALA THR LEU THR SER GLN CYS LEU THR TYR SEQRES 24 B 317 GLU PRO THR GLN ARG PRO SER PHE ARG THR ILE LEU ARG SEQRES 25 B 317 ASP LEU THR ARG LEU HET LB7 A 901 53 HET LB7 B 901 53 HET CL B 902 1 HETNAM LB7 6-[(CYCLOPROPANECARBONYL)AMINO]-4-{[2-METHOXY-3-(1- HETNAM 2 LB7 METHYL-1H-1,2,4-TRIAZOL-3-YL)PHENYL]AMINO}-N- HETNAM 3 LB7 METHYLPYRIDAZINE-3-CARBOXAMIDE HETNAM CL CHLORIDE ION FORMUL 3 LB7 2(C20 H22 N8 O3) FORMUL 5 CL CL 1- FORMUL 6 HOH *76(H2 O) HELIX 1 AA1 ASP A 585 LYS A 587 5 3 HELIX 2 AA2 HIS A 648 GLN A 664 1 17 HELIX 3 AA3 PRO A 694 GLU A 702 1 9 HELIX 4 AA4 PRO A 707 LYS A 728 1 22 HELIX 5 AA5 CYS A 736 ARG A 738 5 3 HELIX 6 AA6 GLY A 763 LEU A 767 5 5 HELIX 7 AA7 SER A 768 ARG A 775 1 8 HELIX 8 AA8 ALA A 780 LEU A 784 5 5 HELIX 9 AA9 ALA A 794 PHE A 809 1 16 HELIX 10 AB1 SER A 819 ARG A 829 1 11 HELIX 11 AB2 LEU A 841 LEU A 849 1 9 HELIX 12 AB3 GLU A 852 ARG A 856 5 5 HELIX 13 AB4 SER A 858 THR A 867 1 10 HELIX 14 AB5 ASP B 585 LYS B 587 5 3 HELIX 15 AB6 HIS B 648 GLN B 664 1 17 HELIX 16 AB7 PRO B 694 GLU B 702 1 9 HELIX 17 AB8 PRO B 707 LYS B 728 1 22 HELIX 18 AB9 GLY B 763 LEU B 767 5 5 HELIX 19 AC1 SER B 768 GLU B 774 1 7 HELIX 20 AC2 ALA B 780 LEU B 784 5 5 HELIX 21 AC3 ALA B 794 PHE B 809 1 16 HELIX 22 AC4 SER B 819 ARG B 829 1 11 HELIX 23 AC5 LEU B 841 LEU B 849 1 9 HELIX 24 AC6 GLU B 852 ARG B 856 5 5 HELIX 25 AC7 SER B 858 ARG B 868 1 11 SHEET 1 AA1 5 ILE A 589 GLY A 598 0 SHEET 2 AA1 5 THR A 601 LEU A 608 -1 O VAL A 603 N GLY A 596 SHEET 3 AA1 5 LEU A 637 LEU A 644 -1 O LEU A 637 N LEU A 608 SHEET 4 AA1 5 GLU A 682 GLU A 688 -1 O ASN A 683 N LEU A 644 SHEET 5 AA1 5 VAL A 673 ARG A 679 -1 N GLY A 675 O VAL A 686 SHEET 1 AA2 2 ILE A 740 ARG A 744 0 SHEET 2 AA2 2 PHE A 754 LEU A 757 -1 O PHE A 754 N ALA A 743 SHEET 1 AA3 5 ILE B 589 GLY B 598 0 SHEET 2 AA3 5 THR B 601 LEU B 608 -1 O VAL B 603 N GLY B 596 SHEET 3 AA3 5 LEU B 637 LEU B 644 -1 O VAL B 643 N ASN B 602 SHEET 4 AA3 5 GLU B 682 GLU B 688 -1 O ASN B 683 N LEU B 644 SHEET 5 AA3 5 VAL B 673 ARG B 679 -1 N GLY B 675 O VAL B 686 SHEET 1 AA4 2 ILE B 740 ARG B 744 0 SHEET 2 AA4 2 PHE B 754 LEU B 757 -1 O LYS B 756 N LEU B 741 CISPEP 1 ILE A 776 PRO A 777 0 12.01 CISPEP 2 ILE B 776 PRO B 777 0 14.49 SITE 1 AC1 17 LEU A 595 GLN A 597 GLY A 598 VAL A 603 SITE 2 AC1 17 VAL A 640 LYS A 642 THR A 687 GLU A 688 SITE 3 AC1 17 TYR A 689 VAL A 690 GLU A 691 HIS A 692 SITE 4 AC1 17 GLY A 693 ARG A 738 ASN A 739 LEU A 741 SITE 5 AC1 17 SER A 758 SITE 1 AC2 17 LEU B 595 GLN B 597 GLY B 598 VAL B 603 SITE 2 AC2 17 VAL B 640 LYS B 642 ALA B 671 THR B 687 SITE 3 AC2 17 GLU B 688 TYR B 689 VAL B 690 GLU B 691 SITE 4 AC2 17 GLY B 693 ARG B 738 LEU B 741 SER B 758 SITE 5 AC2 17 HOH B1008 SITE 1 AC3 1 LEU B 745 CRYST1 71.630 66.970 75.100 90.00 113.34 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013961 0.000000 0.006024 0.00000 SCALE2 0.000000 0.014932 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014502 0.00000